Chun-Ping Xu

Screened microbial strains for biotransformation of betulinic acid and betulin and optimized of bioconversion processes for the application of food additives and drug. Screened microbial strains for bioconversion of sclareol and sclareolide and optimized of bioconversion processes for the application of flavour and food additives. Developed a thermodynamic technique for cytotoxicity analysis of cigarette smoke condensates (CSC) by a microorganism system. Isolated dextransucrase from Leuconostoc

Installed biotransformation Lab including analytical equipments and outsourced to Novacta (UK) for microbial biotransformation and C-LEcta (Germany) to provide enzymatic solutions for biocatalytic applications. Created library of microorganisms rationally designed to possess a high potential of bioconversion ability, specifically for Nicotiana compounds. Screened microbial strains for bioconversion of selected Nicotiana compounds and optimized of bioconversion processes. Cultivated in vitro tobac

Established business relationship with Toshiba Japan and Pulse-Denshi Co., Ltd to order 3CCD camera (OEM version).

Elucidated the interaction between proteins and bacteria using microcalorimeter, atomic force microscope, and parallel plate flow chamber

Developed a novel biosensor using horseradish peroxidase by enzyme technology and detection chemical samples.

Carried out the fermentation (perfusion culture: 500 liters) and purification of Humanized Anti-epidermal Growth Factor Receptor Monoclonal Antibody (a novel targeting anticancer drug) from mammalian cell, which is also the first humanized antibody drug ever approved in China.

Screened microbial strains from oil field for 1,3-Dihydroxyacetone production.